• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Five days of antibiotics fine for children with pneumonia

Bioengineer by Bioengineer
March 8, 2021
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

There are several reasons to use the least amount of antibiotics needed to effectively treat bacterial infections

IMAGE

Credit: McMaster University

Hamilton, ON (March 8, 2021) – Many parents know the struggle of having to make children with pneumonia finish the usual 10-day course in antibiotics despite the child feeling better after a few days of medication.

New research from McMaster University has proven that a five-day course of high-dose amoxicillin will do just as well for children six months to 10 years old with common pneumonia.

“Several studies have proven that adults with pneumonia do fine with short courses of antibiotics, and now we have proved a short course of antibiotics also works for children,” said Dr. Jeffrey Pernica, lead study author, associate professor of pediatrics of McMaster’s Michael G. DeGroote School of Medicine and an infectious disease pediatrician for Hamilton Health Sciences.

The study, involving 281 Ontario children, found that 85.7% of those who received the short course of antibiotics and 84.1% of those who received the longer course of medication were cured two to three weeks later.

The paper was published online by the journal JAMA Pediatrics today.

“The dramatic increase in antimicrobial resistance in the world today is driven by overuse of antibiotics – which has only worsened during the COVID-19 pandemic,” Pernica said. “This is why we need these clinical studies – to figure out how short we can make antibiotic treatment courses for common infections.”

He said there are other reasons to use the least amount of antibiotics needed to effectively treat bacterial infections, including minimizing the costs of medicine.

As well, he noted, a number of conditions including obesity, asthma, and arthritis, have been associated with changes in the human microbiome that can be caused by the use of antibiotics.

The research team is recommending that clinical practice guidelines prepared for health professionals consider recommending five days of amoxicillin for pediatric pneumonia.

###

This study was supported by the PSI Foundation, Pediatric Emergency Research Canada and Hamilton Health Sciences.

The research is part of Canada’s Global Nexus for Pandemics and Biological Threats, an international network based at McMaster, with scientists, clinicians, engineers, social scientists and other experts working collaboratively to prevent future pandemics and mitigate global health threats.

Editors:

A photo of Dr. Jeff Pernica is attached.

For information, please contact:

Veronica McGuire

Media Relations

Faculty of Health Sciences

McMaster University

289-776-6952

[email protected]

Media Contact
Veronica McGuire
[email protected]

Tags: Medicine/HealthPediatrics
Share13Tweet8Share2ShareShareShare2

Related Posts

CSF-1R Inhibition Halts Osteosarcoma Growth

October 7, 2025

SLC25A10 Drives Cisplatin Resistance by Blocking Ferroptosis

October 7, 2025

Fenofibrate Reduces Sepsis-Linked Kidney Injury Through Fatty Acid Oxidation

October 7, 2025

Early Detection of Rare Genetic Disorders Enabled by ‘Genomic-First’ Approach

October 7, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    784 shares
    Share 313 Tweet 196
  • New Study Reveals the Science Behind Exercise and Weight Loss

    98 shares
    Share 39 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    94 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    76 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Optimizing Housing Designs to Cut Multi-Hazard Losses

CSF-1R Inhibition Halts Osteosarcoma Growth

Global Chemical Pollution: Latest Insights from Current Research

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.